Nebula Research & Development »

Amylyx Pharmaceuticals shares owned by Nebula Research & Development

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Nebula Research & Development from 13F filings

Historical chart of Nebula Research & Development investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Nebula Research & Development consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Nebula Research & Development

Quarter filed Position value Share count Share price at filing
2023-09-30 $513k 28k 18.31

More positions owned by Nebula Research & Development

Intuit (INTU)
Power Integrations (POWI)
Archer Daniels Midland Company (ADM)
Federated Hermes CL B (FHI)
Loews Corporation (L)
Hca Holdings (HCA)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)
Abbott Laboratories (ABT)
Insight Enterprises (NSIT)
S&p Global (SPGI)
Peak (DOC)
Nomad Foods Usd Ord Shs (NOMD)
Union Pacific Corporation (UNP)
Cigna Corp (CI)

View all positions for Nebula Research & Development

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
Viking Global Investors
Point72 Asset Management
Millennium Management
Citadel Advisors
Ikarian Capital
Perceptive Advisors
Susquehanna International
Franklin Resources
Goldman Sachs Group
Jane Street
Eventide Asset Management
Marshall Wace
Citigroup
T. Rowe Price Associates

View all funds holding Amylyx Pharmaceuticals